| Date Filed | Type | Description |
| 03/07/2023 |
3/A
| LANGER DENNIS (Director) has filed a Form 3/A on Quoin Pharmaceuticals, Ltd. |
| 01/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Sold 30,000 shares
@ $34.75, valued at
$1M
Exercised 30,000 options to buy
@ $25.39, valued at
$761.7k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/07/2020 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 15,889 shares
@ $0 |
|
| 12/06/2019 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 11,687 shares
@ $0 |
|
| 06/21/2019 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $15.44, valued at
$386k
|
|
| 11/30/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 9,360 shares
@ $0 |
|
| 08/17/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 23,810 shares
@ $16, valued at
$381k
Sold 14,531 shares
@ $16, valued at
$232.5k
|
|
| 06/25/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $13.08, valued at
$327k
|
|
| 06/08/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Sold 3,609 shares
@ $39.3705, valued at
$142.1k
Sold 3,096 shares
@ $39.35, valued at
$121.8k
Sold 13,664 shares
@ $39.35, valued at
$537.7k
Exercised 3,609 options to buy
@ $21.29, valued at
$76.8k
Exercised 3,096 options to buy
@ $21.29, valued at
$65.9k
Exercised 13,664 options to buy
@ $21.29, valued at
$290.9k
|
|
| 06/05/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Sold 30,000 shares
@ $38.9, valued at
$1.2M
Sold 10,000 shares
@ $39.9, valued at
$399k
Sold 8,404 shares
@ $39.9, valued at
$335.3k
Sold 1,227 shares
@ $39.9, valued at
$49k
Exercised 8,404 options to buy
@ $21.29, valued at
$178.9k
Exercised 1,227 options to buy
@ $21.29, valued at
$26.1k
Exercised 10,000 options to buy
@ $24.39, valued at
$243.9k
Exercised 30,000 options to buy
@ $24.4, valued at
$732k
|
|
| 06/01/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Sold 10,000 shares
@ $37.9245, valued at
$379.2k
Exercised 10,000 options to buy
@ $24.39, valued at
$243.9k
|
|
| 05/23/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.63, valued at
$65.8k
|
|
| 05/21/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Sold 10,000 shares
@ $35.9, valued at
$359k
Exercised 10,000 options to buy
@ $24.39, valued at
$243.9k
|
|
| 01/30/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Exercised 360 options to buy
@ $3.42, valued at
$1.2k
|
|
| 11/30/2017 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 7,219 shares
@ $0 |
|
| 11/17/2017 |
4
| LANGER DENNIS (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.97, valued at
$148.5k
|
|
| 07/20/2017 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $3.42, valued at
$85.5k
|
|
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/17/2016 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc |
| 11/08/2016 |
3
| LANGER DENNIS (Director) has filed a Form 3 on PERNIX THERAPEUTICS HOLDINGS, INC. |
| 06/15/2016 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $3.26, valued at
$48.9k
|
|
| 02/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2015 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 06/26/2015 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $13.87, valued at
$208.1k
|
|
| 06/12/2015 |
4
| LANGER DENNIS (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 20,000 shares
@ $0
Granted 30,000 options to buy
@ $1.19, valued at
$35.7k
|
|
| 12/15/2014 |
4
| LANGER DENNIS (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 30,000 options to buy
@ $1.24, valued at
$37.2k
|
|
| 12/04/2014 |
4
| LANGER DENNIS (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 06/20/2014 |
4
| LANGER DENNIS (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $18.73, valued at
$281k
|
|
|